Cited by 97Adenosine and Purinergic SignalingTryptophan and brain disordersTreatment of Major Depression

P2X7 Receptor: A Potential Therapeutic Target for Depression?

Open access
Deussing, Jan M., Arzt, Eduardo·2018·Trends in Molecular Medicine

Abstract

Depression is a prime contributor to global disease burden with 300 million affected patients worldwide. The persistent lack of progress with regards to pharmacotherapy stands in stark contrast to the pandemic magnitude of the disease. Alterations of inflammatory pathways in depressed patients, including altered circulating pro-inflammatory cytokines, have been put forward as a potential pathophysiological mechanism. The P2X7 receptor (P2X7R) plays an important role regulating the release of interleukin-1β and other cytokines. Comprehensive investigation of the P2X7R Gln460Arg missense mutation (rs2230912), which has been associated with major depression and bipolar disorder, has substantially contributed to validate P2X7R as a potential genetic risk factor. We propose that P2X7R is a putative target with good prospects for therapeutic intervention in depressive disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molmed.2018.07.005

Cites

96 of 96 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Neuroinflammation and increased levels of ATP are observed in neuropsychiatry disorders, supposedly correlated with P2X7 receptor activation.

    “Neuroinflammation and increased levels of ATP are observed in neuropsychiatry disorders, supposedly correlated with P2X7 receptor activation [118, 145].”
  • P2X7R has been suggested as a putative target for therapeutic intervention in mood disorders.

    “Among the purinergic receptors, the P2X7R has been suggested as a putative target for therapeutic intervention in mood disorders [33] (Figure 2).”

    From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [33]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 98 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Deussing, J. M., & Arzt, E.
Affiliations
  • Max Planck Institute of Psychiatry (DE)
  • Max Planck Society (DE)
Corresponding author
Deussing, Jan M.
Venue
Trends in Molecular Medicine
Publisher
Elsevier BV
Published
2018-09
Volume
24
Issue
9
Pages
736-747
ISSN
1471-4914 (ISSN-L)
OpenAlex
W2885132844
Cited by
97
References
98
Citations by year
2026: 6 · 2025: 15 · 2024: 11 · 2023: 13 · 2022: 18 · 2021: 11 · 2020: 12 · 2019: 7 · 2018: 3
FWCI
0.97
Type
journal article
Language
en
Open access
Locations
  • Trends in Molecular Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
  • Conicet (submittedVersion, cc-by-nc-nd)
Funders
  • Bundesministerium für Bildung und Forschung (FKZ 01ZX1314H)
  • Consejo Nacional de Investigaciones Científicas y Técnicas
  • Agencia Nacional de Promoción Científica y Tecnológica
  • Max-Planck-Gesellschaft
  • Universidad de Buenos Aires
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
P2X7 receptor, depression, therapeutic target, inflammatory signaling, inflammatory cytokines, IL-1β, genetic risk factors, bipolar disorder, pharmacotherapy
MeSH terms
Animals, Depression, Depressive Disorder, Humans, Inflammation, Cytokines, Mutation, Missense, Polymorphism, Single Nucleotide, Drug Discovery, Receptors, Purinergic P2X7, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review